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Bile acid N-acetylglucosaminyltransferase ctivity has been identified in microsomes from human liver and kidney. In both organs the transferases 
required UDP-N-acetylglucosamine as sugar donor and were mainly active towards ursodeoxycholic acid. Minor activities were observed towards 
amidated ursodeoxycholic, hyodeoxycholic and /Smuricholic acids. No N-acetylglucosaminidation was detectable with the major primary and seu 
ondary bile acids suggesting a specific requirement of the enzymes for bile acids containing 7/I- or 6a-hydroxyl groups. Kinetic parameters and 
other catalytic properties of liver and kidney microsomal N-acetylglucosaminyltransferase activities towards ursodeoxycholic acid are described. 
Glycosidic conjugation; Bile acid; Glycosyltransferase 
1. INTRODUCTION 
N-Acetylglucosaminides of bile acids were recently 
identified in normal human urine [l]. The daily excre- 
tion of these novel bile acid conjugates was comparable 
to the urinary daily excretion of bile acid glucosides 
[1,2] and bile acid glucuronides [3]. Whereas 
characteristics of the biosynthesis of bile acid glucosides 
[4,5] and glucuronides [6-91 could be elucidated from 
studies of the corresponding glycosyltransferases in 
man, nothing was known on the enzyme(s) catalyzing 
bile acid N-acetylglucosaminidation. The present report 
describes a rapid and sensitive assay procedure which 
enabled the characterization of the biosynthesis of bile 
acid N-acetylglucosaminides. 
2. MATERIALS AND METHODS 
Sources of chemicals were the same as described in previous papers 
[4,6]. UDP-iV-acetyl-D-glucosamine [glucosamine-i4C (II)], 284 
mCi/mmol, and UDP-N-acetyl-D-glucosamine [glucosamine-6-‘H 
(N)], 19 Ci/mmol were obtained from NEN chemicals, Dreieich. 
Human tissue specimens were obtained from a similar collective of 
surgical patients or organ donors as described [5]. Kidney samples 
were restricted to the cortical region. Only tissues with apparently 
normal histology were used. 
Human tissue specimens could be stored for maximally 4 weeks at 
- 30°C without a marked loss of bile acid N-acetylglucosaminyltrans- 
ferase activity. Homogenization of tissues and preparation of 
microsomes by differential centrifugation was performed as described 
in a previous report [6]. 
Unless otherwise stated, bile acid N-acetylglucosaminyltransferase 
activity in human kidney or liver towards ursodeoxycholic acid was 
determined as follows: approximately lO-301(g of microsomal protein 
was incubated in a reaction mixture which contained in a total volume 
of 30 pl 0.1 mM ursodeoxycholic acid, 50 CM UDP-N-acetyl-D- 
[3H]glucosamine (0.05 &i), 0.05 mM ADP for inhibition of 
nucleotide pyrophosphatase and the following additions for incuba- 
tions with renal or hepatic microsomes, respectively: 0.1 M sodium 
acetate (pH 6.2), 2 mM MgClr and 0.002% (w/v) Brij 58 with renal 
microsomes; 0.1 M 4-morpholineethanesulfonic a id (Mes)-KOH (pH 
6.4) and 1 mM MgClz with hepatic microsomes. ADP (0.05 mM) had 
no inhibitory effect on bile acid N-acetylglucosaminidation a d main- 
tained UDP-iV-acetylglucosamine l vels in 15-min incubations at 
about 95% and 99% of the initial values as compared to 77% and 
93% without ADP in kidney and liver microsomes, respectively, as 
determined by thin layer chromatography (cf. below). After 15 min at 
37°C the reactions were terminated with 30 d 0.7 M Glycine-HCl (pH 
2.7) containing 0.8 M sodium chloride. The water phase was extracted 
for 5 min with 300 d water-saturated ethyl acetate resulting in transfer 
of about 95% of the reaction product into the organic phase. The 
unreacted UDP-N-acetylglucosamine r mained in the water phase (> 
99.9%). A 200 ~1 aliquot of the organic phase was counted for 
radioactivity in 5 ml Optifluor (Packard) scintillation cocktail. 
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For identification of bile acid N-acetylglucosaminides the reaction 
products were purified on a Sep-Pak Cis cartridge (see legend to Table 
I) and were incubated with or without N-acetylglucosaminidase as
described [l]. Ethanol extracts of these incubation mixtures were ap- 
plied to silica gel 60 thin-layer plates which were developed with n- 
butanol/acetic acid/water (5015110, v/v) and analyzed in a thin-layer 
chromatogram scanner (Berthold, Wildbad). When incubations were 
performed in the absence of N-acetylglucosaminidase ingle spots of 
the following N-acetylglucosaminides could be detected: N- 
acetylglucosaminides of ursodeoxycholic, RF 0.609; glycoursodeox- 
ycholic, RF 0.235; tauroursodeoxycholic, RF 0.158; hyodeoxycholic, 
RF 0.591 and fl-muricholic acids, RF 0.535, respectively. After in- 
cubation of reaction products in the presence of N-acetylgluco- 
saminidase these spots were shifted to a position identical to that of 
authentic N-acetyl[%]glucosamine (RF 0.266). 
Protein was determined as described in a previous report [9]. 
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3. RESULTS AND DISCUSSION 
3.1. Substrate specificity and tissue distribution 
Analysis of reaction mixtures after incubation of 
renal or hepatic microsomes with various bile acids as 
acceptor substrates and UDP-N-acetylglucosamine as 
donor substrate showed that formation of N- 
acetylglucosaminides mainly occurred in the presence 
of ursodeoxycholic acid (Table I). Amidation of ur- 
sodeoxycholic acid with glycine or taurine, change of 
the position and configuration of the hydroxyl group 
from 70 to 6a (hyodeoxycholic acid versus ursodeox- 
ycholic acid) or the presence of a third hydroxyl group 
in the bile acid molecule as in /3-muricholic acid led to 
a marked decrease in the rate of N-acetyl- 
glucosaminidation (Table I). No reaction was detect- 
able (< 1 pmol/min/mg protein) with the primary bile 
acids cholic and chenodeoxycholic acids, the major 
secondary bile acids lithocholic and deoxycholic acids 
and the following other bile acids: 3o, 6fi-di-hydroxy- 
S/3-cholanoic, ursocholic (ICY, 7p, 12a-trihydroxy-5/3- 
cholanoic) and hyocholic (ICY, 6a, 7a-trihydroxy-So- 
cholanoic) acids. These results suggest a specificity of 
the enzymes from liver and kidney towards the 7& or 6 
a-hydroxyl group of preferentially dihydroxy as com- 
pared to trihydroxy bile acids. The restricted bile acid 
specificity of N-acetylglucosaminyltransferases in in 
vitro assays is in accordance with in vivo findings since 
ursodeoxycholic acid was the only bile acid that could 
be identified as N-acetylglucosaminide from human 
urine [l]. 
In contrast to the activities observed in kidney and 
liver (Table I), no ZV-acetylglucosaminyl transfer from 
UDP-N-acetylglucosamine (50 PM or 6 PM) to ur- 
sodeoxycholic acid (0.1 mM) was detectable with 
Table I 
Bile acid substrate specificity of N-acetylglucosaminyltransferases 
Bile acid Relative activity 
Kidney Liver 
(To) Vo) 
Ursodeoxycholic acid (3a, 70) 1OOa 61 
Glycoursodeoxycholic acid (3a, 7P) 19 3.1 
Tauroursodeoxycholic acid (3a, 7/3) 35 12 
Hyodeoxycholic acid (3a, 6o) 9.4 13 
P-Muricholic acid (3o, 68, 7p) 7.4 4.0 
Enzyme activities were determined as described in Materials and 
Methods at bile acid concentrations of 0.1 mM with the following 
modifications: microsomal protein (100 fig) was incubated in a total 
volume of 180 ~1; the sugar donor was UDP-N-acetyl-D- 
[‘?]glucosamine (6 pM, 0.3 pCi); the incubations were terminated 
with 800 ~1 ethanol and protein was removed by centrifugation; the 
reaction products were purified from the supernatants by adsorption 
to a Sep-Pak Crs cartridge [lo] and analyzed by thin-layer 
chromatography as described in Materials and Methods. Position and 
configuration of hydroxyl groups in the bile acid skeleton are given in 
parentheses. 
a Definition of 100% value: 13.5 pmol of product formed per min per 
mg of protein 
12 
homogenate or microsomes from different segments of 
human intestinal mucosa (ileum, colon, sigmoid and 
rectum). 
3.2. Characteristics of N-acetylglucosaminyltrans- 
ferases in liver and kidney 
The influence of pH on the formation of ursodeox- 
ycholic acid N-acetylglucosaminide was similar for the 
enzymes from liver and kidney. Enzyme activities were 
optimal between pH 6.1-6.4 in renal microsomes and 
pH 6.1-6.7 in hepatic microsomes and showed a steep 
decline of activity towards pH 5.0 and 8.0 (not shown). 
Divalent metal ions exhibited a weak stimulatory ef- 
fect on enzyme activities towards ursodeoxycholic acid. 
Compared to the control without metal ion and con- 
taining 10 mM EDTA, the kidney enzyme was max- 
imally stimulated to about 140% in the presence of 2 
mM Mg’ + ,2 mM Mn2 + or 10 mM Ca* + . The liver en- 
zyme showed maximal activation to about 160% in the 
presence of 1 mM Mg2 + , 0.1 mM Mn2 + or 0.5 mM 
Ca2+. In contrast to the enzyme from renal 
microsomes, the metal ion dependence of the liver en- 
zyme was only observed at a low concentration of UDP- 
N-acetylglucosamine (6 PM). No influence of these 
metal ions on hepatic enzyme activity was detectable at 
50 FM UDP-N-acetylglucosamine. Zn2 + was not 
stimulatory but inhibitory to the enzymes from liver 
and kidney in concentrations >O.Ol mM. 
Since membrane-bound enzymes may be activated by 
the addition of detergents [l l] the influence of the non- 
ionic detergents Brij 58 and Triton X-100 (O.OOl-0.2%, 
w/v or v/v, respectively) was studied on ursodeox- 
ycholic acid N-acetylglucosaminidation in liver and 
kidney microsomes. Whereas the effect of Triton X-100 
on both hepatic and renal enzymes and Brij 58 on the 
liver enzyme was not activatory but inhibitory with in- 
creasing concentration (> 0.002~0), Brij 58 led to a 
1.5-fold activation of the renal enzyme at a concentra- 
tion of 0.002%. 
Double-reciprocal plots of N-acetylglucosaminyl- 
transferase activities towards ursodeoxycholic acid with 
UDP-N-acetylglucosamine as varied substrate yielded a 
straight line with renal microsomes whereas with 
hepatic microsomes plots were concave downwards 
(Fig. 1). The same curved double-reciprocal plots were 
obtained with liver microsomes in the presence or 
absence of the detergent Brij 58 (0.002%, w/v). The 
data in Fig. 1 indicate that rates of ursodeoxycholic acid 
N-acetylglucosaminidation in hepatic microsomes are 
higher at low concentrations of UDP-ZV-acetylglucosa- 
mine than calculated from extrapolation of the plots at 
high concentrations of the sugar donor. Therefore, 
destruction of UDP-N-acetylglucosamine in other 
metabolic microsomal pathways cannot explain these 
results. Whether or not nonlinearity of double- 
reciprocal plots could be explained by a negatively 
cooperative binding mechanism [12] or UDP-N- 
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Kinetic constants of bile acid-N-acetylglucosaminyltransferases in kidney and liver 
Kinetic constants Kidney Liver 
Low UDPGNA? High UDPGNAca 
K,,, for ursodeoxycholic acid 93.0 + 23.5 21.4 + 5.3 31.8 f 8.9 
K,,, for UDP-N-acetylglucosamine 409.8 + 138.9 2.2 + 1.3 51.2 + 26.2 
V max 295.6 + 95.5 1.0 + 0.5 3.9 + 0.8 
Values are given as mean + SD which were obtained from the following number of organ samples: kidney, n = 5; liver, n = 4. The kinetic 
parameters for the kidney enzyme were calculated according to Florini and Vestling [13] from double-reciprocal plots of initial rates as a function 
of the concentration of ursodeoxycholic acid (0.01-o. 1 mM) at various fixed concentrations of UDP-iV-acetylglucosamine (25 FM, 35 PM, 50 pM, 
100 PM) yielding an intersecting pattern of straight lines. The kinetic data for the liver enzyme were determined from Lineweaver-Burk plots as 
follows: with ursodeoxycholic acid (0.01-0.1 mM) as variable parameter at either low (6 PM) or high (50 PM) concentration of UDP-N- 
acetylglucosamine yielding the K,,,-values for ursodeoxycholic acid; with UDP-N-acetylglucosamine as variable parameter by extrapolating the 
regions in double reciprocal plots tending towards linearity at low or high concentrations of UDP-N-acetylglucosamine (see Fig. 1) yielding the 
K,,,-values for UDP-N-acetylglucosamine and the V ,,,,-values. “UDPGNAc, UDP-N-acetylglucosamine; Km, pM; V,,,,,, pmol/min/mg protei 1. 
acetylglucosamine to the liver enzyme or by the ex- 
istence of two hepatic isoenzymes for the synthesis of 
ursodeoxycholic acid N-acetylglucosaminide should be 
analyzed with a purified enzyme preparation and not 
with a heterogenous microsomal fraction. 
The apparent kinetic constants for microsomal N- 
acetylglucosaminyltransferase activities from kidney 
and liver towards ursodeoxycholic acid are summarized 
in Table II. Due to the nonlinearity of double- 
reciprocal plots with liver N-acetylglucosaminyltrans- 
ferase (Fig. 1) the kinetic parameters for this enzyme 
were calculated at low and high concentrations of UDP- 
N-acetylglucosamine (see legend to Table II). As may 
be seen from Table II the enzymes from kidney and 
0.0 0.1 0.2 0.3 0.4 
NDP-N-acetylglucosmin~‘~d 
0.5 
Fig. 1. Double reciprocal plots of initial rates of N-acetylgluco- 
saminidation as a function of the concentration of UDP-N-acetyl- 
glucosamine at an ursodeoxycholic acid concentration of 0.1 mM 
with microsomes from liver (0) and kidney (0). The depicted plots 
show typical results from a single microsomal preparation of each 
organ; v, pmol/min/mg protein. 
liver show marked differences in kinetic parameters 
especially with respect to the &-values for UDP-N- 
acetylglucosamine and the I&,-values. From these 
kinetic parameters, however, a similar efficiency of ur- 
sodeoxycholic acid N-acetylglucosaminidation in 
kidney and liver can be calculated based on the ratio of 
the I’,,,- to &,-values for UDP-N-acetylglucosamine at 
saturating concentrations of ursodeoxycholic acid: 0.7 
for the renal enzyme and 0.45 for the hepatic enzyme at 
low concentrations of UDP-N-acetylglucosamine. 
The results of the present study show that the occur- 
rence of bile acid N-acetylglucosaminides in urine of 
man [l] can be explained by the existence of bile acid N- 
acetylglucosaminyltransferases in liver and kidney. The 
bile acid specificity of these enzymes is interesting 
because ursodeoxycholic acid was the preferred 
substrate in N-acetylglucosamine conjugation, and this 
bile acid was recently shown to improve liver function 
in patients with cholestatic liver disease [14]. Further 
studies are needed to elucidate whether or not a correla- 
tion exists between N-acetylglucosaminidation and the 
pathophysiological effects of ursodeoxycholic acid in 
liver disease. 
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